Showing results for "#Serum Institute of India"
Vaccine hesitancy greatest threat in overcoming Covid: Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla on Wednesday termed vaccine hesitancy as the greatest threat in overcoming the COVID-19 pandemic while...
Will be able to manufacture, supply 10 cr Covishield doses in June:...
In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because...
Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 118 cr
Serum Institute of India CEO Adar Poonawalla on Monday offloaded his entire stake in Panacea Biotec amounting to 5.15 per cent shareholding of the...
SII doing best to ramp up COVID-19 vaccine production, says CEO
Serum Institute of India (SII) is doing its best to ramp up the production of COVID-19 vaccine Covishield to cater to demand in the country, Adar...
Serum says will raise monthly production to 10 cr doses by Aug, Bharat...
Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan...
Covishield production in full swing in Pune, says Poonawalla
Serum Institute of India CEO Aadar Poonawalla has said that the production of COVID-19 vaccine Covishield is in full swing in Pune and he will review...
Will return to India in a few days, says Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla has said he will return to India from London in a few days.
Serum Institute defends Covishield pricing, says initial rates based...
Serum Institute of India (SII), which makes the most used COVID-19 vaccine in the country, on Saturday defended pricing Covishield vaccine at 1.5...